Welcome to DailyUpdates Neurodegenerative & Neuroelectrophysiological Disorders channel - the R&D community's bulletin of breaking research, clinical trials and drug development news. This page will update each day. You have access for 1 more day(s). To receive DailyUpdates by e-mail register here

DailyUpdates by e-mail - the publication tracker for the drug discovery community

Neurodegenerative & Neuroelectrophysiological Disorders channel

---

---

• Recommend DailyUpdates
• Other Therapeutic Channels
• UpdatesPlus
• Consultancy
• Modify Subscription
• Past Content
• Submit to DailyUpdates
• Contact

	If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, , links through to full analyses relating to pharmaceutical/market developments relating to this work
Useful Links: Recommend DailyUpdates UpdatesPlus Consultancy Modify your subscription Search past content Submit a paper to DailyUpdates Contact LeadDiscovery	Today's journal articles 4 - Aryl - 4 - oxo - N - phenyl - 2 - aminylbutyramides as acetyl - and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure - activity relationship based on molecular interaction fields. Do you need further information on any of the agents being evaluated in the trial(s) below?  Let us know... New Clinical Trials Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) Previous Journal Entries Oral treatment with a {gamma}-secretase inhibitor improves long-term potentiation in a mouse model of Alzheimer's disease. Pharmacological characterization of a novel positive modulator at alpha(4)beta(3)delta-containing extrasynaptic GABA(A) receptors. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Proton pump inhibitor Lansoprazole is a nuclear liver X receptor agonist. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Inhibition of Glycogen Synthase Kinase 3{beta} (GSK3{beta}) Decreases Inflammatory Responses in Brain Endothelial Cells. Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) FoxP3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells. Predictors of long-term treatment effect of rivastigmine in Alzheimer's disease: a role for beta-amyloid plasma levels? Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB(1) Receptor Antagonism. Anticonvulsive Effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury. Development of (S) - N(6) - (2 - (4 - (Isoquinolin - 1 - yl)piperazin - 1 - yl)ethyl) - N(6) - propyl - 4,5,6,7 - tetrahydrobenzo[d] - thiazole - 2,6 - diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson's Disease Animal Models. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease. Site - specific labeling of 'second generation' annexin V with (99m)Tc(CO)(3) for improved imaging of apoptosis in vivo. Neuroprotective effect of asymmetrical dimethylarginine against 1-methyl-4-phenylpyridinium ion-induced damage in PC12 cells. Benzimidazole - and indole - substituted 1,3' - bipyrrolidine benzamides as histamine H(3) receptor antagonists. Predictive screening model for potential vector - mediated transport of cationic substrates at the blood - brain barrier choline transporter. A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase - B inhibitors. Discovery of a benzoxazine derivative promoting angiogenesis in vitro and in vivo. Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit.	Today's News Items NeuroSearch announces positive top-line results from Phase III Huntexil study in Huntington\'s disease (the MermaiHD study) Training Courses & Meetings No events listed Previous News Items Synosia Announces Positive Interim Results for Potential First-in-Class Treatment for Parkinson’s Disease Allon initiates trial to expand safety profile for dementia drug davunetide For faster discovery, automatically organize PubMed results into categories